Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
NCT00733850
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
85
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
Kanglaite Injection plus gemcitabine
DRUG:
Gemcitabine
Sponsor
KangLaiTe USA